At KSQ Therapeutics, we are always looking for strong leaders to join our team.
Contact us about current job opportunities.
To be able to manage our flow of candidates we do not accept unsolicited resumes from any source other than directly from the candidates for current or future positions. Submission of unsolicited referrals and/or resumes in advance of a signed agreement between KSQ and the recruiter are deemed gratuitous and KSQ will not be obligated or bound in any way to pay any referral or other fees if such person is hired. Thank you in advance for your adherence to our process. For any hiring needs, please contact us.
At KSQ Therapeutics, we seek to understand the role of every human gene in each disease, each tissue, and each cell that we study. This comprehensive approach has resulted in a massive, experimentally derived dataset with remarkable concordance to past successes and failures in oncology and immuno-oncology product development. Utilizing this approach, we also identified a number of opportunities for the development of new medicines. As a result, we have aggressively invested in these distinct, highly validated pathways for new drug development with the expectation that the medicines we create may become the next breakthrough products for patients.
Founded in late 2015, KSQ is a clinical-stage biotech that has rapidly advanced the field of CRISPR-enabled functional genomics, from in vitro cell autonomous screens to more complex genome-scale screens of immune cells in vivo. The company has expanded the scope of its technology to include multiple cell types and to unlock areas beyond oncology. KSQ is led by a team of accomplished industry experts in drug discovery and development.
KSQ is seeking a highly motivated and versatile Associate Director, Formulation Development. Reporting to the Head of Small Molecule & Oligonucleotide CMC, the successful candidate will be responsible for the phase appropriate technical development and manufacturing of small molecule drug products using an external network of providers.
This position is integral to the advancement of KSQ’s lead small molecule KSQ-4279, and will collaborate closely with internal and external stakeholders in the broader program team. The scope of this role encompasses authorship of CMC content for regulatory submissions in collaboration with other KSQ functional groups, as well as developing and actively managing appropriate timelines/budgets for all activities.
This position may also provide support for KSQ’s cell therapy programs (sgRNA formulation) on a part time basis.
© 2022 KSQ Therapeutics, Inc. All rights reserved.